CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Genomics
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 15, 2026

Silencing the Spark: CRISPR/Cas9 Genome Editing in Weakly Electric Fish
Published on: October 27, 2019
Haitao Yang1, MariaLynn Jaeger2, Averi Walker2
1Laboratory for Cancer Genome Editing, Zhuhai Lifecode Medical Technologies. Inc. Department of Prenatal Diagnosis, Huizhou 2nd Hospital for Children and Women, #101 University Road, Tangjiawan, Zhuhai, 518900, Guangdong, China.
CRISPR/Cas genome editing advances biomarker discovery for breast cancer personalized medicine. This review explores its impact on identifying cancer programs driving tumorigenesis, metastasis, and treatment resistance.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: